Rare Tumors
Rare Tumors is a peer-reviewed, open access journal, which focusses on the study, diagnosis and treatment of rare cancers. The journal covers the diagnosis, classification, and treatment of rare tumors and haematological malignancies for physicians and medical scientists interested in uncommon neoplasms. Please see the Aims and Scopes tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).Why publish in Rare Tumors?
- Listed on PubMed and freely available via PubMed Central
- Indexed in the Directory of Open Access Journals (DOAJ) and in the Web of Science Emerging Citation Index (ESCI)
- Rigorous peer review of your research
- Multidisciplinary audience
- Prompt online publication
- High visibility for global exposure
Open access article processing charge (APC) information
The APC for this journal is currently 2100 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/raretumors
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Contact
Please direct any queries to RTU@sagepub.com
Rare Tumors is an open access, peer-reviewed international medical journal devoted entirely to the study, diagnosis, and treatment of rare cancers. The journal covers the diagnosis, classification, and treatment of rare tumors and hematological malignancies for physicians and medical scientists interested in uncommon neoplasms. The primary intent of the journal will be to publish clinically relevant information that will directly improve the care of patients with rare cancers. Basic science studies of interest to those treating rare malignancies will also be considered for publication when relevant. A special section of the journal is dedicated to Case Reports: we would like to invite clinicians and researchers to send us their reports.
| Dian Wang | Rush University Medical Center, Chicago, USA |
| Parul Barry | University of Pittsburgh Medical Center, Pittsburgh, PA, USA |
| Brian Van Tine | Washington University Med Ct, St Louis, MO, USA |
| Ramon Andrade de Mello | Department of Medical Oncology, Oncology Portuguese Institute of Porto Francisco Gentil, Porto, Portugal |
| Armando Bartolazzi | Department of Pathology, St. Andrea University Hospital, Rome, Italy |
| Alan T. Blank | Rush University Medical Center, Chicago, IL, USA |
| Beth Z. Clark | UPMC Magee-Womens Hospital, Pittsburgh, PA USA |
| Giacomo Deiro | University of Turin, Italy |
| Guy Eslick | Harvard School of Public Health, MA, USA |
| Nicola Fazio | Istituto Europeo di Oncologia, Milan, Italy |
| Thorvardur Halfdanarson | Mayo Clinic College of Medicine, Rochester, Minnesota, USA |
| Angela C. Hirbe | Washington University School of Medicine, St. Louis, MO, USA |
| Sergio Huerta | Dallas VA Medical Center Surgical Services, Dallas, Texas, USA |
| Thomas Kim | Rush University Medical Center, Chicago, IL, USA |
| Sameera Kumar | Fox Chase Cancer Center, Philadelphia, PA, USA |
| Yun Li | University of California San Francisco, San Francisco, CA, USA |
| Diane Ling | Keck School of Medicine, University of Southern California, Los Angeles, CA, USA |
| Simon Lo | Department of Radiation Oncology, Case Western Reserve University, UH Seidman Cancer Center, Cleveland, OH, USA |
| Oliver Micke | Department of Radiotherapy and Radiation Oncology, Franziskus Hospital, Bielefeld, Germany |
| Timothy A.O. Oluwasola | College of Medicine, University of Ibadan, Ibadan, Nigeria |
| Ken Tatebe | Rush University Medical Center, Chicago, IL, USA |
| Jonathan C. Trent | The University of Texas MD Anderson Cancer Center, TX, USA |
| Mark Gerard Trombetta | Department of Radiation Oncology, West Penn Allegheny Health System Allegheny General Hospital, PA, USA |
| Meng Welliver | Comprehensive Cancer Center, The Ohio State University, USA |
| Breelyn Wilky | University of Colorado, Anschutz Medical Center, Aurora, CO, USA |
| Malaka Ameratunga, MBBS, PhD, FRACP | Monash University, Australia |
| Andrea Angioi ,MD, FASN | ARNAS Brotzu, Cagliari, Italy |
| Xiaolan Feng ,MD, PhD, FRCPC | Cumming School of Medicine, University of Calgary, Canada |
| Mohammad-Salar Hosseini, MD, MPH | Tabriz University of Medical Sciences, Tabriz, Iran |
| Dr. Alejandro Ibáñez-Costa, PhD | Department of Cell Biology, Physiology, and Immunology, University of Córdoba |
| Pamela Milito ,MD | IRCCS Policlinico San Donato, San Donato Milanese, Mi, Italy |
| John Park ,BSc(Med) MBBS, MPH, FRACP, PhD | Macquarie University, NSW, Australia |
| Himanshu Narayan Singh ,M Tech, PhD | Memorial Sloan Kettering Cancer Center, New York, USA |
Manuscript submission guidelines can be accessed on Sage Journals.